跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
COVISHIELD - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
COVISHIELD
Authorized
STANDARD
COVISHIELD
Verity Pharmaceuticals Inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
1cb99c48b0025add
Company
Verity Pharmaceuticals Inc.
Type
Standard
Approval Details
Approval Id
1cb99c48b0025add
Drug Approval Canada Name
COVISHIELD
Product Name
COVISHIELD
Status
Authorization By Interim Order Expired
Status Date
2021-09-16
Original Market Date
2021-03-03
Din
02512947
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intramuscular
Schedule
COVID-19 - IO - Authorization , Schedule D
Atc Original
J07BN02 COVID-19, VIRAL VECTOR, NON-REPLICATING
Atc Name
j 07 bn 02
Aig Number
0162722001
Company Name
Verity Pharmaceuticals Inc.
Company Address
2560 Matheson Blvd. E., Suite 220, Mississauga, Ontario, Canada, L4W 4Y9
Company Detail Path
/organization/verity-pharmaceuticals-inc
Company Information
Pharmaceutical Company Name
Verity Pharmaceuticals Inc.
Country Name
Canada
Province Name
British Columbia
City Name
vancouver,british columbia,country_ca
Address
2600-595 Burrard St
Active Ingredients
CHADOX1-S [RECOMBINANT]
50000000000 VP / 0.5 ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
1cb99c48b0025add
Type
Standard
Back to Health Canada Approvals